Daily Roundup – Wednesday, February 18, 2009
February 18, 2009 at 9:46 pm EST | Tags: News
-Pfizer owes Wisconsin $150M+ for illegal drug price inflating. Ouch. [Yahoo!Finance]
-Agennix, maker of milk protein lactoferrin, is merging with GPC Biotech. [Bloomberg]
-Neuropharm’s version of controlled-release Prozac failed in a Phase 3 autism trial. The result: investors dumped their shares and the stock nosedived 66%. Yikes! [Reuters]
-Kythera Biopharmaceuticals, developer of deoxycholate injections for fat and lipomas, got a boost with an additional $10M. [BioSpace]
-Novartis and Merck Sales Reps do it better! [FiercePharma]
Image from Yahoo! Messenger Blog
![[Loading...]](http://www.iguanabio.com/wp-content/themes/IguanaBio/images/ajax-loader.gif){kind=small}
